SuperCrowd
New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
Aspire BioPharma, Inc.
aspirebiolabs.com · PR · Filed Oct 31, 2023
Aspire BioPharma, Inc. filed a Form C — new offering — with the SEC on Oct 31, 2023. The Regulation Crowdfunding offering seeks $150,000, up to a maximum of $5,000,000 on Republic. Investors receive: Preferred Stock at $0.80. The offering closes 01-31-2024.
| Target raise | $150,000 |
|---|---|
| Maximum raise | $5,000,000 |
| Security | Preferred Stock @ $0.80 |
| Closes | 01-31-2024 |
| Portal | Republic |
Filing documents
ASPIREFORMC
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.